Abstract & Article Details
Short Communication • Vol.3, Issue 12 • ISSN: 2766-2276 • Open Access • CC BY 4.0
Open Access
Short Communication
Vol.3, Issue 12 January 11, 2022
Efficacy and Tolerability of Dolutegravir-Based Dual-Therapies in HIV Naive and Switch Patients
DOI:
10.37871/jbres1395
Abstract
Objectives: The introduction of dual-therapy both as preferred starting therapy and in switches has been a revolution, allowing the same efficacy results to be obtained as therapies with more Active Ingredients (AI) with a lower risk of toxicity and interactions. The aim of the study is to analyze the efficacy, tolerability and reasons for switching patients to dolutegravir-based dual therapies.
Research Topics
How to Cite
Jose Manuel Vinuesa-Hernando*, Galadriel Pellejero-Sagastizabal, Mercedes Gimeno-Gracia, Isabel Sanjoaquin-Conde, Maria Jose Crusells-Canales, Raquel Fresquet-Molina and Raquel Gracia-Piquer (2022). Efficacy and Tolerability of Dolutegravir-Based Dual-Therapies in HIV Naive and Switch Patients. Journal of Biomedical Research & Environmental Sciences, 3(12). https://doi.org/10.37871/jbres1395
Article Information
| Journal | Journal of Biomedical Research & Environmental Sciences (JBRES) |
|---|---|
| ISSN | 2766-2276 |
| DOI | DOI 10.37871/jbres1395 |
| Volume / Issue | Vol. 3, Issue 12 |
| Published | January 11, 2022 |
| Article Type | Short Communication |
| Pages | 018-019 |
| License | CC BY 4.0 — Open Access |
| Publisher | SciRes Literature LLC, Sheridan, WY, USA |
| Language | English |
Published under CC BY 4.0 — free to share, copy, adapt, and redistribute with attribution.
Certificate of Publication
Certificate verifies that this article was peer-reviewed and published in the Journal of Biomedical Research & Environmental Sciences.